From GlobeNewswire: 2025-05-15 21:00:00

Tenaya Therapeutics Inc. granted stock options to purchase 461,000 shares of common stock to three new non-executive employees at an exercise price of $0.4373 per share. Each option has a ten-year term and vests over four years, with 1/4th vesting on the one-year anniversary of hire. The options were granted as an inducement for employment in accordance with NASDAQ Listing Rule 5635(c)(4). Tenaya Therapeutics focuses on developing potentially curative therapies for heart disease, with a pipeline including gene therapies for hypertrophic cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy, as well as a small molecule inhibitor for heart failure. Visit www.tenayatherapeutics.com for more information.



Read more at GlobeNewswire: Tenaya Therapeutics Reports Inducement Grants under NASDAQ